Cardiac Dimensions
  • Home
  • Patient Resources
    • Overview
    • Treatment Options
    • Technology
    • Clinical Experience
    • Current Studies
  • Physician Resources
    • Overview
    • Treatment Options
    • Technology
    • Clinical Experience
    • Current Studies
    • Publications
    • Instructions for Use
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Investors
    • Press Releases
    • Careers
    • Intellectual Property
    • Login
  • Contact

Patient Resources

  • Overview
  • Treatment Options
  • Technology
  • Clinical Experience
  • Current Studies

Clinical Experience with the CARILLON Device

Clinical experience with the CARILLON® Mitral Contour System® includes numerous studies undertaken at multiple centers worldwide.

The clinical results from these studies show an overall reduction in the amount of mitral regurgitation which in turn has shown improvement in the patients participating in the study. Specifically, improvement in exercise capacity has been shown through the six minute walk test ("6MWT"), a standard exercise test, and the New York Heart Association ("NYHA") classification.

These improvements are usually seen immediately after implant of the CARILLON device and appear to be sustained through the 24-month follow-up timeframe for most patients.

TITAN™ Clinical Study Functional Results

 

CAUTION: The CARILLON® Mitral Contour System® is CE-Marked and approved for sale in the European Union and elsewhere in the world.
In the United States, the CARILLON Mitral Contour System is an investigational device and limited by Federal law to investigational use.

Copyright © 2013 Cardiac Dimensions, Inc. All rights reserved. 5540 Lake Washington Blvd. NE Kirkland, WA 98033

Terms of Use | Privacy Policy | Legal Notice